Literature DB >> 8380954

Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease.

M Boiocchi1, R Dolcetti, V De Re, A Gloghini, A Carbone.   

Abstract

The recent detection of clonal episomes of Epstein-Barr virus (EBV) in a significant proportion of Hodgkin's disease (HD) cases has suggested a re-evaluation of the possible pathogenetic role of EBV in the development of the disease. Here we report that in two EBV-positive HD, arisen in human immunodeficiency virus-1-infected drug users, a unique episomal EBV genome was detected in multiple metachronous HD lesions of each patient. These findings demonstrated that the same EBV-positive cellular clone was present in multiple localizations of HD as well as in specimens taken at different times. Combined in situ hybridization and immunohistological analyses evidenced EBV genome and EBV-encoded latent membrane protein-1 on Reed-Sternberg cells. Therefore, the data strongly support the possibility of a causal role for EBV in the pathogenesis of HD.

Entities:  

Mesh:

Year:  1993        PMID: 8380954      PMCID: PMC1886842     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Association of Epstein-Barr virus genome with mixed cellularity and cellular phase nodular sclerosis Hodgkin's disease subtypes.

Authors:  M Boiocchi; V De Re; R Dolcetti; A Carbone; A Scarpa; F Menestrina
Journal:  Ann Oncol       Date:  1992-04       Impact factor: 32.976

2.  Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study.

Authors:  L M Weiss; Y Y Chen; X F Liu; D Shibata
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

3.  Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.

Authors:  H Herbst; F Dallenbach; M Hummel; G Niedobitek; S Pileri; N Müller-Lantzsch; H Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease.

Authors:  P H Levine; D V Ablashi; C W Berard; P P Carbone; D E Waggoner; L Malan
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

5.  Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease.

Authors:  B Johansson; G Klein; W Henle; G Henle
Journal:  Int J Cancer       Date:  1970-11-15       Impact factor: 7.396

6.  Extended epidemic of Hodgkin's disease in high-school students.

Authors:  N J Vianna; P Greenwald; J N Davies
Journal:  Lancet       Date:  1971-06-12       Impact factor: 79.321

7.  Childhood social environment and Hodgkin's disease.

Authors:  N Gutensohn; P Cole
Journal:  N Engl J Med       Date:  1981-01-15       Impact factor: 91.245

Review 8.  Epidemiology of Hodgkin's disease.

Authors:  N Gutensohn; P Cole
Journal:  Semin Oncol       Date:  1980-06       Impact factor: 4.929

9.  A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin.

Authors:  H Browne; G Smith; S Beck; T Minson
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

10.  Hodgkin's disease in patients with previous infectious mononucleosis.

Authors:  G Kvåle; E A Høiby; E Pedersen
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

View more
  2 in total

Review 1.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

2.  Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease.

Authors:  M A Vasef; O W Kamel; Y Y Chen; L J Medeiros; L M Weiss
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.